Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CI 912

Known as: CI-912 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Zonisamide (ZNS) is a new antiepileptic drug initially introduced in Europe, Japan and the United States (US) in the late 1980… Expand
  • table 1
  • table 2
1990
1990
The effects of a novel anticonvulsant, zonisamide (3-sulfamoylmethyl-1,2-benzisoxazole), on photically induced seizures were… Expand
Highly Cited
1987
Highly Cited
1987
Summary: Nine patients with refractory partial seizures were evaluated in a pilot study of a new anticonvulsant compound… Expand
1987
1987
Summary: The effect of the experimental antiepileptic drug zonisamide (l,2‐benzisoxazole‐3‐methanesulfon‐amide, ZNS) on the… Expand
1987
1987
The effects of 1,2-benzisoxazole-3-methanesulfonamide (zonisamide, AD-810, CI-912), an antiepileptic compound, on the central… Expand
1987
1987
The effects of 1,2-benzisoxazole-3-methanesulfonamide (zonisamide, AD-810, CI-912), an antiepileptic compound, on the… Expand
Highly Cited
1986
Highly Cited
1986
Zonisamide (CI-912) is an experimental antiepileptic drug. Since this drug is to be evaluated initially as an add-on medication… Expand
1986
1986
Summary: Effects of zonisamide (AD‐810, CI‐912) were examined on tungstic acid gel‐induced thalamic generalized seizures and… Expand
1985
1985
Brain capillary transit of CI-912 was studied in vivo after a single capillary transit by the intracarotid injection technique… Expand
1984
1984
Summary: We studied the pharmacokinetics of CI-912 (1,2-benziosoxazole-3-methanesulfonamide) in 10 adults with refractory partial… Expand